Monte Financial Group’s AstraZeneca AZN Stock Holding History

Monte Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Sell	9,071 -1,169	-11%	-$225K	0.64%	46
2025 Q4	$1.88M	Hold	10,240	–	–	0.7%	43
2025 Q3	$1.57M	Sell	10,240 -1,109	-10%	-$168K	0.58%	50
2025 Q2	$1.59M	Sell	11,349 -13	-0.1%	-$1.82K	0.62%	49
2025 Q1	$1.54M	Hold	11,362	–	–	0.67%	40
2024 Q4	$1.49M	Hold	11,362	–	–	0.64%	40
2024 Q3	$1.77M	Sell	11,362 -1,036	-8%	-$167K	0.73%	36
2024 Q2	$1.93M	Buy	12,398 +2,620	+27%	+$394K	0.85%	37
2024 Q1	$1.32M	Buy	+9,778	New	+$1.29M	0.58%	40

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Monte Financial Group's AZN Position: Q1 2026 in Review

Monte Financial Group reduced its AstraZeneca (AZN) stake by 11% in Q1 2026, selling an estimated $225K and leaving 9,071 shares worth $1.79M. The position accounts for 0.64% of the portfolio, ranked #46.

Monte Financial Group first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.93M in Q2 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Monte Financial Group held 9,071 shares of AstraZeneca worth $1.79M as of Q1 2026.
Monte Financial Group sold 1,169 AstraZeneca shares in Q1 2026, an estimated $225K.
AstraZeneca made up 0.64% of Monte Financial Group's portfolio in Q1 2026, its #46 holding.
Monte Financial Group first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
Monte Financial Group's AstraZeneca position peaked at $1.93M in Q2 2024.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Monte Financial Group's 13F filing for Q1 2026, filed 14 May 2026.